# Pilot Study of APD209 in Cancer Cachexia

> **NCT00895726** · PHASE2 · COMPLETED · sponsor: **Acacia Pharma Ltd** · enrollment: 13 (actual)

## Conditions studied

- Cancer-related Cachexia

## Interventions

- **DRUG:** APD209

## Key facts

- **NCT ID:** NCT00895726
- **Lead sponsor:** Acacia Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-11
- **Final completion:** 2012-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895726, "Pilot Study of APD209 in Cancer Cachexia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00895726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*